The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Educating hematology-oncology fellows about how to communicate with patients about cancer clinical trials: A needs assessment.
 
Martina Cathryn Murphy
Honoraria - IntegrityCE
 
Naomi D. Parker
No Relationships to Disclose
 
Tithi B. Amin
No Relationships to Disclose
 
Susan Eggly
No Relationships to Disclose
 
Daphne R. Friedman
Research Funding - Janssen; Karyopharm Therapeutics
 
Maria Sae-Hau
Stock and Other Ownership Interests - ARGX (Argenx) (I); GPCR (Structure Therapeutics) (I); LLY (eli Lilly) (I); MRNA (Moderna) (I); NVO (novo nordisk) (I); RCKT (Rocket Pharmaceuticals) (I); UNH (United Healthcare) (I); VKTX (Viking Therapeutics) (I)
Research Funding - AbbVie Inc.; Amgen Inc.; Astra; Bristol-Myers Squibb; Zeneca Pharmaceuticals, LP
 
Andrea Phillips Sitlinger
Honoraria - Agios; BeiGene; CLL Society; Innate Pharma; OncTalk; Patient Power; TG Therapeutics; Virginia Oncology Associates
Research Funding - Genmab; Innate Pharma; Loxo/Lilly; MEI Pharma
 
Stephanie A.S. Staras
No Relationships to Disclose
 
Leah Szumita
No Relationships to Disclose
 
Elisa S. Weiss
Research Funding - Abbvie; Amgen; AstraZeneca; Bristol Myers Squibb Foundation; Kite, a Gilead Company; LP Therapeutics
 
Easton N. Wollney
No Relationships to Disclose
 
Kevin B. Wright
No Relationships to Disclose
 
Carma L Bylund
No Relationships to Disclose